← Leaderboards
Salwa A Elgebaly
Nour Heart, Inc.
$3,632,845
Attributed
$3,632,845
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$3,632,845 · 1
By mechanism
R44$3,632,845 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Aftercare”
- Xuping Xie · University Of Texas Med Br Galveston$10,877,958
- Michael E. Roth · Public Health Institute$8,303,012
- Leonard R. Henry · Northside Hospital Atlanta$4,036,775
- Cindy S Chu · University Of Oxford$3,470,639
- Emil Schueler · University Of Tx Md Anderson Can Ctr$3,375,134
- Amy M Moskop · Medical College Of Wisconsin$3,357,500
Research focus
AftercareAgedAgreementAnimalsApoptosisBioenergeticsBiological MarkersBloodBlood SpecimenBrain DeathCadaverCanis FamiliarisCapitalCardiacCardioprotectionCell InjuryChemistryClinical PathologyClinical ProtocolsCommercializationCryopreservationDesignDoseAcute Toxicity
Grant awards (3)
Nourexalâ¢: A Novel Bioenergetic Drug to Increase Donor Heart Utilization$1,923,922
R44 · FY2025 · HL · contact PI
Nourexalâ¢: A Novel Bioenergetic Drug to Increase Donor Heart Utilization$50,000
R44 · FY2025 · HL · contact PI
Nourexalâ¢: A Novel Bioenergetic Drug to Increase Donor Heart Utilization$1,658,923
R44 · FY2024 · HL · contact PI